← Eichor
Study identifier: NCT05884138 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients

Condition: Sarcopenia  ·  Sponsor: Chungnam National University Hospital

PhaseNA
Planned participants40
Who can joinAll sexes, 20 Years to 80 Years
Healthy volunteersNo

About this study

Sarcopenia can be easily observed in patients with hemodialysis. However, there were few studies on the precise concept and diagnostic criteria for sarcopenia in patients with hemodialysis. The investigators have already recognized the sarcopenia-associated mortality and morbidity in patients with hemodialysis. However, intervention studies on hemodialysis patients with sarcopenia have not been conducted until now. In 2021, the investigators conducted a pilot study to evaluate the effectiveness of the combined exercise and nutrition intervention for sarcopenia in patients with hemodialysis to confirm the effectiveness. This study is a follow-up study, conducted as a randomized controlled trial.

This description comes directly from the study's public registry record.

Talk to the study team

Hyon-Seung Yi  ·  82-10-2411-9766  ·  jmpbooks00@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Chungnam National University HospitalDaejeon, South Korea, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05884138